Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merro Pharmaceutical, based in Dalian, China, is a long-standing pharmaceutical enterprise specializing in the development and production of both Traditional Chinese Medicine (TCM) and Western chemical drugs. The company operates through several specialized divisions, including the Dalian Merro Traditional Chinese Medicine Factory, which focuses on high-quality TCM formulations for gastrointestinal and cardiovascular health. Merro is recognized for its strong brand presence in the Chinese domestic market and its large-scale, GMP-certified manufacturing capabilities. Its product portfolio includes a wide range of antibiotics, digestive aids, and respiratory treatments. While the company's former public shell underwent a major corporate restructuring in 2015, the core pharmaceutical business continues to operate as a significant private entity under the Merro Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Merro Chinese Traditional Medicine Factory.